MARKET

ZOM

ZOM

Zomedica Corp
AMEX
0.2150
+0.0051
+2.43%
Opening 15:28 10/04 EDT
OPEN
0.2180
PREV CLOSE
0.2099
HIGH
0.2180
LOW
0.2101
VOLUME
4.95M
TURNOVER
564.36K
52 WEEK HIGH
0.6000
52 WEEK LOW
0.1750
MARKET CAP
210.69M
P/E (TTM)
-11.1399
1D
5D
1M
3M
1Y
5Y
Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference
Zomedica Corp. (NYSE American:ZOM) announced today that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the Dawson James Securities Small Cap Growth Conference on October 12, 2022...
ACCESSWIRE · 6d ago
Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association
Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, is pleased to announce that the PulseVet system has been named the Official Shock W...
ACCESSWIRE · 09/06 10:30
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.
Benzinga · 08/23 11:36
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that Pamela Nichols, DVM has been appointed to its Board of Directors and is j...
ACCESSWIRE · 08/23 10:30
Zomedica GAAP EPS of -$0.005, revenue of $4.2M
Zomedica press release (<span class="ticker-...
Seekingalpha · 08/15 21:31
Zomedica Pharmaceuticals Q2 EPS $(0.01), Same YoY, Sales $4.20M Up From $15.69K YoY
Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $4.20 million in sales this quarter. This is a 26.66K percent
Benzinga · 08/15 21:23
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues
Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three and six month periods ended Jun...
ACCESSWIRE · 08/15 21:20
Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference
Ann Arbor, Michigan--(Newsfile Corp. - August 9, 2022) - Zomedica Corp. (NYSE American: ZOM) today announced that Larry Heaton, CEO, will be attending the Q3 Virtual Investor Summit. During the presentation, Zomedica Chief Executive Officer, Larry Heaton, ...
Newsfile · 08/09 11:00
More
About ZOM
Zomedica Corp. is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. The Company is developing point-of-care diagnostic platform, which is based on miniaturized laser-based Raman spectroscopy technology and is designed to detect pathogens in companion animals. Its product portfolio includes diagnostics and therapeutic medical devices that emphasize patient health. It offers TRUFORMA is a diagnostic biosensor platform and the first five assays for the detection of thyroid disorders in dogs and cats and adrenal disorders in dogs. The TRUFORMA platform uses bulk acoustic wave (BAW) technology to provide a non-optical and fluorescence free detection system for use at the point-of-care. The TRUFORMA also offers complete control over the testing process and allow veterinarians to make clinical decisions. PulseVet platform provides treatment for musculoskeletal issues in horses and small animals.

Webull offers kinds of Zomedica Corp stock information, including AMEX:ZOM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZOM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZOM stock methods without spending real money on the virtual paper trading platform.